ESC 365 - Balancing atrial fibrillation burden with stroke risk and the need for anticoagulation

Open Access

Balancing atrial fibrillation burden with stroke risk and the need for anticoagulation

Session: The clinical continuum of atrial fibrillation: balancing risks to optimise outcomes

Topic: Oral Anticoagulant Drugs

Speaker: Doctor E. Svennberg (Stockholm, SE)

Sponsored by Pfizer/BMS Alliance

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Emma Svennberg

Karolinska Institute, Stockholm (Sweden)

46 presentations

26 followers

4 more presentations in this session

Welcome and introduction

Speaker: Professor G. Lip (Liverpool, GB)

Updates on the latest real-world evidence on the use of direct oral anticoagulants (DOAC) in non-valvular atrial fibrillation (NVAF)

Speaker: Professor G. Lip (Liverpool, GB)

From data to decision-making: applying evidence and guidelines to clinical practice

Speaker: Professor D. Connolly (Smethwick, GB)

Interactive discussion and Q&A

Speaker: Professor G. Lip (Liverpool, GB) Doctor E. Svennberg (Stockholm, SE) Professor D. Connolly (Smethwick, GB)

Access the full session

The clinical continuum of atrial fibrillation: balancing risks to optimise outcomes

Speakers: Doctor E. Svennberg, Professor G. Lip, Professor G. Lip, Professor D. Connolly, Professor G. Lip...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources